The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 475,441 |
| Depreciation & amortization | 29,192 |
| (increase) decrease in value of equity securities | -2,397 |
| Increase in value of equity method investments | 11,599 |
| Amortization of securities, net | 12,827 |
| Accretion of purchased loans | 5,148 |
| Share-based compensation | 10,722 |
| Gain on assets | 2,665 |
| Gain on repurchase of subordinated debentures | 1,882 |
| Provision for credit losses - loans | 24,100 |
| Recovery of credit losses - unfunded commitments | -1,000 |
| Recovery of credit losses - investment securities | -2,195 |
| Deferred income taxes | 10,348 |
| Increase in cash value of life insurance | 6,061 |
| Originations of mortgage loans held for sale | 737,233 |
| Proceeds from sales of mortgage loans held for sale | 631,918 |
| Accrued interest receivable | -11,190 |
| Other assets | 25,930 |
| Accrued interest payable and other liabilities | -10,347 |
| Net cash provided by operating activities | 399,281 |
| Net decrease (increase) in federal funds sold | 725 |
| Net increase in loans | 828,361 |
| Purchases of investment securities available-for-sale | 113,840 |
| Proceeds from maturities of investment securities available-for-sale | 422,151 |
| Proceeds from maturities of investment securities held-to-maturity | 16,255 |
| Purchases of equity securities | 5,000 |
| Proceeds from sales of equity securities | 2,429 |
| Purchases of other investments | 0 |
| Proceeds from redemption of other investments | 13,221 |
| Oreo improvements | 3,493 |
| Proceeds from foreclosed assets held for sale | 11,629 |
| Proceeds from sale of sba loans | 10,639 |
| Purchases of premises and equipment | 22,265 |
| Proceeds from sales of premises and equipment | 18,809 |
| Return of (purchase of) investment on cash value of life insurance | -6,784 |
| Net cash (used in) provided by investing activities | -470,317 |
| Net increase (decrease) in deposits | 333,660 |
| Net (decrease) increase in securities sold under agreements to repurchase | -6,547 |
| Increase in fhlb and other borrowed funds | 0 |
| Decrease in fhlb and other borrowed funds | 100,500 |
| Retirement of subordinated debentures | 158,049 |
| Proceeds from exercise of stock options | 602 |
| Repurchase of common stock | 82,220 |
| Dividends paid on common stock | 158,920 |
| Net cash used in financing activities | -171,974 |
| Net change in cash and cash equivalents | -243,010 |
| Cash and cash equivalents beginning of year | 910,347 |
| Cash and cash equivalents end of year | 667,337 |
HOME BANCSHARES INC (HOMB)
HOME BANCSHARES INC (HOMB)